Ambeed 大中华区 CN | ZH

中文 - ZH English - EN

Ambeed.cn

搜索

关键字搜索批量搜索

首页 收藏 购物车0
首页 /
抑制剂/激动剂
细胞生物学 药物研究 酶学
/
细胞培养
细胞凋亡 经典阳性药 药物分析 酶抑制剂 代谢酶
/
HMGCR
铁死亡抑制剂 细胞诱导 心血管系统 药物标准品 单磷酸肌苷脱氢酶抑制剂
/ Simvastatin

辛伐他汀 /Simvastatin {[allProObj[0].p_purity_real_show]}

货号：A198975 同义名： MK 733;SVA

Simvastatin（MK 733）是一种HMG-CoA还原酶的竞争性抑制剂，Ki为0.2 nM。

Simvastatin 化学结构 CAS号：79902-63-9
Simvastatin 化学结构
CAS号：79902-63-9
Simvastatin 3D分子结构
CAS号：79902-63-9
Simvastatin 化学结构 CAS号：79902-63-9
Simvastatin 3D分子结构 CAS号：79902-63-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} 		{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Simvastatin 纯度/质量文件 产品仅供科研

货号：A198975 标准纯度： {[allProObj[0].p_purity_real_show]}
批次查询： 批次纯度:

全球学术期刊中引用的产品

• Cell, 2024, 101755. Ambeed. [ A399663 ]
• EMBO J., 2024. Ambeed. [ A295334 ]
• JMC, 2024, 67(20): 18265-18289. Ambeed. [ A538667 , A341145 , A117430 , A172297 ]
• JMC, 2024. Ambeed. [ A210558 , A1518164 ]
• Cell Death Discov., 2024, 10, 436. Ambeed. [ A384235 ]
更多 >

Simvastatin 生物活性

描述 The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA )reductase is the rate-limiting step in cholesterol synthesis, converting HMG-CoA to mevalonic acid, which through a series of additional steps is converted to cholesterol. Simvastatin is a long-established HMG-CoA reductase inhibitor.[4].Simvastatin suppresses cholesterol synthesis in mouse L-M cell, rat H4II E cell, and human Hep G2 cell with IC50s of 19.3 nM, 13.3 nM and 15.6 nM, respectively[5]. Simvastatin causes a dose-dependent increase in serine 473 phosphorylation of Akt within 30 minutes, with maximal phosphorylation occurring at 1.0 µM. Simvastatin (1.0 μM) enhances phosphorylation of the endogenous Akt substrate endothelial nitric oxide synthase (eNOS), inhibits serum-free media undergo apoptosis and accelerates vascular structure formation[6]. Simvastatin shows anti-inflammatory effects, reduces anti-CD3/anti-CD28 antibody-stimulated proliferation of PB-derived mononuclear cells and synovial fluid cells from rheumatoid arthritis blood, as well as IFN-γ release at 10 μM. Simvastatin (10 μM) also blocks cell-mediated macrophage TNF-γ release induced via cognate interactions[7]. Simvastatin (5 μM) significantly reduces the expression of ABCA1 in astrocytes and neuroblastoma cells, the expression of apolipoprotein E in astrocytes, and increases cyclin-dependent kinase 5 and glycogen synthase kinase 3β expression in SK-N-SH cells[8].
作用机制 Simvastatin acts by decreasing cholesterol synthesis and by increasing low density lipoprotein (LDL) catabolism via increased LDL receptor activity. It also produces a beneficial moderate decrease in plasma triglycerides and a small, although significant, increase in high density lipoprotein (HDL)-cholesterol.[3].

Simvastatin 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
HEK293 cells Function assay Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate, IC50=4.4 μM 22587986
HepG2 cells Function assay In vitro inhibitory activity was evaluated on cholesterol biosynthesis in HepG2 cells, IC50=0.04 μM 14741258
human A549 cells Cytotoxic assay 72 h Cytotoxicity against human A549 cells after 72 hrs by MTT assay, IC50=16.3 μM 23570542
human HS68 cells Cytotoxic assay Cytotoxicity against human HS68 cells after 72 hrs by MTT assay, IC50=26.4 μM 23570542

Simvastatin 动物研究

Dose Rat: 1 mg/kg - 20 mg/kg[3] (i.g.), 10 mg/kg - 40 mg/kg[4] (p.o.) Mice: 10 mg/kg - 100 mg/kg[5] (i.g.)
Administration i.g., p.o.

Simvastatin 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00605449 Type 2 Diabetes Mellitus Phase 1 Completed - United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 <<
NCT00351286 Peripheral Arterial Disease ... 展开 >> Intermittent Claudication 收起 << Phase 2 Unknown - Russian Federation ... 展开 >> Municipal Healthcare Institution, Gatchina Central District Hospital Gatchina, Russia, Russian Federation, 188300 Russian State Medical University at Filatov City Hospital #15 Moscow, Russia, Russian Federation, 111539 Vishnevsky Institute of Surgery, Russian Medical Academy of Science Moscow, Russia, Russian Federation, 113811 Municipal Prophylaxis and Treatment Institution, City Hospital #13 N. Novgorod, Russia, Russian Federation, 603018 Municipal Medical Institution City Hospital #1 of Saratov Saratov, Russia, Russian Federation, 410056 St. Petersburg State Healthcare Institution, Research for Emergency Medical Care St. Petersburg, Russia, Russian Federation, 192242 St. Petersburg State Healthcare Institution, Hospital #2 St. Petersburg, Russia, Russian Federation, 194354 St. Petersburg State Healthcare Institution, Hospital #26 St. Petersburg, Russia, Russian Federation, 196247 State Educational Institution of Higher Professional Education St. Petersburg, Russia, Russian Federation, 197089 St. Petersburg State Healthcare Institution, Pokrovskaya Hospital St. Petersburg, Russia, Russian Federation, 199106 收起 <<
NCT01097785 Heart Failure Not Applicable Completed - United States, Missouri ... 展开 >> University of Missouri Columbia, Missouri, United States, 65212 收起 <<

Simvastatin 参考文献

[1] P A Todd,et al. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs.1990 Oct;40(4):583-607.

[2] Jennifer G Robinson, Simvastatin: present and future perspectives. Expert Opin Pharmacother. 2007 Sep;8(13):2159-27.

[3] P A Todd,et al. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia. Drugs.1990 Oct;40(4):583-607.

[4]Kureishi, Y., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med, 2000. 6(9): p. 1004-10.

[5]Leung BP, et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol. 2003 Feb 1;170(3):1524-30.

[6]Weijiang Dong, et al. Differential effects of simvastatin and CS-514 on expression of Alzheimer’s disease-related genes in human astrocytes and neuronal cells. J Lipid Res. 2009 Oct; 50(10): 2095-2102.

Simvastatin 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.39mL

0.48mL

0.24mL

11.95mL

2.39mL

1.19mL

23.89mL

4.78mL

2.39mL

Simvastatin 技术信息

CAS号79902-63-9
分子式C25H38O5
分子量 418.566
别名 MK 733;SVA
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Inert atmosphere,2-8°C
溶解度

DMSO: 50 mg/mL(119.46 mM)，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

无水乙醇: 100 mg/mL(238.91 mM)，配合低频超声助溶，注意：无水乙醇开封后，易挥发，也会吸收空气中的水分，导致溶解能力下降，请避免使用开封较久的乙醇
动物实验配方

2% DMSO+30% PEG 300+5% Tween80+water 10 mg/mL

Tags: Simvastatin | 79902-63-9 | MK 733 | MK733 | MK-733 | HMG-CoA Reductase (HMGCR) Inhibitor | Metabolic Enzyme/Protease | Autophagy | Apoptosis | HMG-CoA Reductase (HMGCR) | Autophagy | Mitophagy | Apoptosis | Ferroptosis | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | Simvastatin 纯度/质量文件 | Simvastatin 生物活性 | Simvastatin 细胞研究 | Simvastatin 动物研究 | Simvastatin 临床数据 | Simvastatin 参考文献 | Simvastatin 实验方案 | Simvastatin 技术信息

Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
    • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质用途提供服务。

    尊敬的 Ambeed 客户您好，
    请您选择所在区域，我们将转接对应客服为您服务！

    热门区域

    A

    B

    C

    F

    G

    H

    J

    L

    N

    Q

    S

    T

    X

    Y

    Z

    热 A B C F G H J L N Q S T X Y Z